Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Biotech
Sanofi, Wave post updates in race to end AATD’s 40-year drought
The companies are taking different tacks to treat the protein deficiency, but are currently focused on different subsets of the patient population.
Darren Incorvaia
May 18, 2026 4:30pm
Fierce Pharma
Sanofi invests $294M to scale Toronto AI hub
May 5, 2026 9:21am
Sanofi CFO defends Hudson's legacy, accepts R&D ‘setbacks’
Apr 23, 2026 4:04am
Small pools, big ideas: Rare disease community reimagines trials
Apr 17, 2026 3:00am
Biogen links up with Alloy platform to boost ASO drug development
Apr 7, 2026 6:00am
Sanofi bispecific sees respiratory ph. 2 wins, eczema fail
Apr 7, 2026 4:10am